Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.
about
Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell trackingField evaluation of a push-pull system to reduce malaria transmissionMicrofluidic Production of Biodegradable Microcapsules for Sustained Release of Hydrophilic Actives.Drug delivery to the posterior segment of the eye for pharmacologic therapy.Development of topical microbicides to prevent the sexual transmission of HIVTaccalonolides: Novel microtubule stabilizers with clinical potential.Surface characterisation of bioadhesive PLGA/chitosan microparticles produced by supercritical fluid technology.Injectable sustained release microparticles of curcumin: a new concept for cancer chemopreventionFunctionalizable hydrogel microparticles of tunable size and stiffness for soft-tissue filler applications.β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol.The role of small molecules in musculoskeletal regeneration.Imparting superhydrophobicity to biodegradable poly(lactide-co-glycolide) electrospun meshes.Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.Intracellular release of 17-β estradiol from cationic polyamidoamine dendrimer surface-modified poly (lactic-co-glycolic acid) microparticles improves osteogenic differentiation of human mesenchymal stromal cellsSynthesis and characterization of a poly(lactic-co-glycolic acid) core + poly(N-isopropylacrylamide) shell nanoparticle systemElectrospun poly(L-lactide) fiber with ginsenoside rg3 for inhibiting scar hyperplasia of skin.Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheresPEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy.Clinically viable magnetic poly(lactide-co-glycolide) particles for MRI-based cell tracking.Uniform iron oxide hollow spheres for high-performance delivery of insoluble anticancer drugs.Sustained release of hydrophobic drugs by the microfluidic assembly of multistage microgel/poly (lactic-co-glycolic acid) nanoparticle composites.Surgical wound healing using hemostatic gauze scaffold loaded with nanoparticles containing sustained-release granulocyte colony-stimulating factor.Poly(lactide-co-glycolide) microspheres for MRI-monitored delivery of sorafenib in a rabbit VX2 model.Sustained-release G-CSF microspheres using a novel solid-in-oil-in-oil-in-water emulsion method.Beyond the imaging: limitations of cellular uptake study in the evaluation of nanoparticles.Thermodynamic Insights and Conceptual Design of Skin-Sensitive Chitosan Coated Ceramide/PLGA Nanodrug for Regeneration of Stratum Corneum on Atopic DermatitisCombination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapyOcular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) filmsEnhanced oral bioavailability of acetylpuerarin by poly(lactide-co-glycolide) nanoparticles optimized using uniform design combined with response surface methodology.Microspheres Assembled from Chitosan-Graft-Poly(lactic acid) Micelle-Like Core-Shell Nanospheres for Distinctly Controlled Release of Hydrophobic and Hydrophilic Biomolecules.Sustained release of matrix metalloproteinase-3 to trabecular meshwork cells using biodegradable PLGA microparticlesTailoring sub-micron PLGA particle release profiles via centrifugal fractioning.Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy.Self-healing microencapsulation of biomacromolecules without organic solventsThe use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.Highly loaded, sustained-release microparticles of curcumin for chemoprevention.Microparticles produced by the hydrogel template method for sustained drug deliveryDevelopment of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague.
P2860
Q27025163-014208CE-2B7D-4AD6-824B-B8BC8D2DF0F6Q28546820-3A24BF8C-A183-4F79-9199-84CA574C6407Q30101067-D6E34A97-A804-47FD-92DA-8E160354FCD6Q30478379-49203D40-41A4-405B-8512-AAD0DA5DD55DQ33625073-1B1E5792-8568-457A-96F2-EF5FC914784FQ33759235-0E965CB6-C565-45E7-BF39-DF540D307EACQ33843464-3BAC2DA2-718E-4666-B411-C23167B7811EQ33892008-961D757C-93FD-4911-9E9B-9E3AD90EA816Q33931667-DAAE72B9-AB58-4D68-9BCA-7DF09DD80FFFQ34147976-16FA718A-95B0-4262-959B-516A1BCE1A76Q34324995-5723EB69-DE28-4146-AD49-A0B7CF53CBC3Q34346326-0C1BA0F9-4A58-40F8-89A7-5A3AAC5A1C17Q34434257-B28A8A8A-6017-461B-A56B-C0163E37632FQ34455041-7D5EBB3E-9C4C-411C-B669-ECD9C8F2A377Q34571360-2D69AD9D-6265-49B2-8C45-76A2F0010404Q34606728-42A97C95-71D9-495B-AF04-372E82ABB15EQ34626900-C87A183C-1A68-4161-8F7F-F2D73C1D1A37Q34851005-8E9340B5-B5B4-4568-8964-C4C44017F52BQ34901313-074ED57C-DD2F-4FCA-A3F4-C5AF86497461Q35006422-A487EABC-18A9-4898-B955-5956CA61CBC7Q35106957-432EB252-D603-4E77-8F3C-90B1451C0279Q35137690-ABD0E05F-0B35-429B-8AA9-C62999EA47D1Q35224930-A2936A1D-4B34-4901-AB5D-8F5F4FA5385AQ35605280-AA009B00-6C11-42B1-8DAA-C4CA9301D160Q35838170-E0CC04BB-0023-4FCE-9CFB-782594DB7832Q36177546-DD0B60E2-C1FA-4659-8FFD-A8BC19719645Q36247616-95E537F1-55C3-4C7B-AC7A-6C4B72622DD1Q36370027-64316BF0-E9A7-4309-9EA9-7EDE38926363Q36696647-2CA36652-09D9-4066-B656-5C71B97FA805Q36696921-FA4AF4EC-1580-48E6-BAEA-5FE3F0721707Q37042544-C3143EB0-DBD9-4504-8BFB-D2EBAC3FF037Q37062748-368B65D4-4577-40FD-B111-680053E5FE45Q37146470-B1AC20AF-6B60-49C8-A917-421F193F5DF0Q37165806-71916950-C887-4000-9D1E-59C9F6AAEB7CQ37260459-E25FE83C-C02B-4973-BCD7-968625EA0400Q37279904-75AE3449-E075-4FC5-AC9C-C4528DC8EF0CQ37438909-CB74CD2E-8A26-4624-A5D8-BFF292B16A7AQ37518860-C87B0A69-934F-4710-BACA-77FC2526CAC2Q37576526-E5863E1E-E610-4D5D-86F8-F314D2792EDBQ37588454-2BDEB054-3181-4AC8-98E4-20E1202561DA
P2860
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.
@en
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.
@nl
type
label
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.
@en
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.
@nl
prefLabel
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.
@en
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.
@nl
P1476
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.
@en
P2093
Christian Wischke
Steven P Schwendeman
P304
P356
10.1016/J.IJPHARM.2008.04.042
P407
P577
2008-05-07T00:00:00Z